- Conditions
- Abdominal Wall Hernia, Pancreatic Diseases, Bowel Disease, Gastric Disease
- Interventions
- Acetaminophen Injectable Product, Sodium Chloride 0.9%, Intravenous
- Drug
- Lead sponsor
- Kathirvel Subramaniam
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 180 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018 – 2020
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
Source: ClinicalTrials.gov public record
Updated Jan 27, 2021 · Synced May 21, 2026, 10:53 PM EDT